{"id":5462,"date":"2022-05-02T09:00:00","date_gmt":"2022-05-02T07:00:00","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-offentliggor-arsredovisning-for-helaret-2021\/"},"modified":"2022-05-02T09:00:00","modified_gmt":"2022-05-02T07:00:00","slug":"stayble-therapeutics-offentliggor-arsredovisning-for-helaret-2021","status":"publish","type":"cision-feed","link":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-offentliggor-arsredovisning-for-helaret-2021\/","title":{"rendered":"Stayble Therapeutics offentligg\u00f6r \u00e5rsredovisning f\u00f6r hel\u00e5ret 2021"},"content":{"rendered":"<p style=\"margin-bottom:0pt;margin-top:12px\"><span><span style=\"font-family:arial,helvetica,sans-serif;font-size:9pt\"><strong>\u00c5rsredovisningen finns tillg\u00e4nglig som bifogat dokument samt p\u00e5 Bolagets hemsida (https:\/\/staybletherapeutics.com\/sv\/).<\/strong><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stayble Therapeutics AB (\u201dStayble\u201d eller \u201dBolaget\u201d) offentligg\u00f6r h\u00e4rmed \u00e5rsredovisning avseende hel\u00e5ret 2021.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5462"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/cision-feed"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5462"}],"version-history":[{"count":0,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5462\/revisions"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}